Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James R. Mcnab currently holds 51,021 shares of TITAN PHARMACEUTICALS INC (TTNP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James R. Mcnab has been a net seller of TTNP stock. They have purchased $669.5K and sold $3.4M worth of shares.
James R. Mcnab's most recent insider trade was on Jan 28, 2022, when they sold 51,021 shares at $0.00 per share.
James R. Mcnab serves as Executive at TITAN PHARMACEUTICALS INC (TTNP). They have executed 59 insider transactions totaling $4.1M over their tenure at the company.
James R. Mcnab holds the position of Executive at TITAN PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
James R. Mcnab has shown a selling trading pattern, with $669.5K in total purchases and $3.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James R. Mcnab was on Jun 18, 2012, when they sold $712.5K worth of CRIS shares. This transaction involved 150,000 shares at $4.75 per share.
James R. Mcnab currently owns 51,021 shares of TITAN PHARMACEUTICALS INC (TTNP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James R. Mcnab's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James R. Mcnab has 59 Form 4 filings on record as an insider at TITAN PHARMACEUTICALS INC.
Set alerts for James R. Mcnab and 40,000+ other insiders.